Guangshengtang (300436.SZ): Letermovir tablets obtain drug registration certificate.

Financial APP news from Securities Times, Guangshengtang (300436.SZ) announced that recently, the company's innovative drug holding subsidiary Fujian Guangsheng Zhonglin Biotechnology Co., Ltd. has received the "Drug Registration Certificate" issued by the National Medical Products Administration for the company's ritonavir tablets, which will further enhance the company's competitiveness in the antiviral field.